(Q44481626)

3 December 2017

title

Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients (English)

1 reference

3 December 2017

main subject

cardiovascular disease

1 reference

Hayet Fellah

1

1 reference

3 December 2017

Moncef Feki

2

1 reference

3 December 2017

Mohamed Hsairi

3

1 reference

3 December 2017

Haifa Sanhaji

4

1 reference

3 December 2017

Neziha Kaabachi

5

1 reference

3 December 2017

Taieb Ben Abdallah

6

1 reference

3 December 2017

Ziad A Massy

7

1 reference

3 December 2017

Hedi Ben Maiz

8

1 reference

3 December 2017

Bernard Lacour

9

1 reference

3 December 2017

Abderraouf Mebazaa

10

1 reference

3 December 2017

language of work or name

1 reference

1 May 2003

1 reference

Clinical Chemistry and Laboratory Medicine

3 December 2017

published in

1 reference

3 December 2017

volume

41

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

675-680

1 reference

Impaired homocysteine metabolism and atherothrombotic disease

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Hyperhomocysteinemia as a risk factor for venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Associations of homocysteine, C-reactive protein and cardiovascular disease in patients with renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Plasma C-reactive protein in haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Homocysteine and lipid peroxidation products: important atherosclerosis risk factors in renal allograft recipients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Hyperhomocysteinaemia and MTHFR C677T gene polymorphism in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.102

21 January 2018

Identifiers

DOI

10.1515/CCLM.2003.102

1 reference

3 December 2017

1 reference